百科

3-(4-溴苯基)丙烯酸乙酯

3-(4-溴苯基)丙烯酸乙酯

CAS号：15795-20-7

英文名：(E)-3-(4-bromo-phenyl)-acrylic acid ethyl ester

分子式

C11H11BrO2

熔点

密度

分子量

255.108

沸点

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

3-(4-溴苯基)丙烯酸乙酯

英文名称

(E)-3-(4-bromo-phenyl)-acrylic acid ethyl ester

中文别名

英文别名

Ethyl 3-(4-Bromophenyl)acrylate、ETHYL3-(4-BROMOPHENYL)ACRYLATE

CAS号

15795-20-7

分子式

C11H11BrO2

分子量

255.108

精确质量

253.994

PSA

26.3

LOGP

3.0254

下游产品

共找到49个下游商品 >

(E)-4-bromocinnamic acid hydrazide

(E)-4-bromocinnamic acid hydrazide

ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanoate

ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanoate

(6S)-2-nitro-6-[((2E)-3-{4-[6-trifluoromethyl-3-pyridinyl]phenyl}-2-propenyl)oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine

(6S)-2-nitro-6-[((2E)-3-{4-[6-trifluoromethyl-3-pyridinyl]phenyl}-2-propenyl)oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine

ethyl (2E)-3-(4-{[(3R)-1-(4-chlorobenzoyl)-3-pyrrolidinyl]amino}phenyl)acrylate

ethyl (2E)-3-(4-{[(3R)-1-(4-chlorobenzoyl)-3-pyrrolidinyl]amino}phenyl)acrylate

3-(4-bromophenyl)-2,2-dimethylcyclopentanone

3-(4-bromophenyl)-2,2-dimethylcyclopentanone

3-[4-(Naphthalen-2-yloxy)-phenyl]-propionic acid ethyl ester

3-[4-(Naphthalen-2-yloxy)-phenyl]-propionic acid ethyl ester

下游产品

(E)-4-bromocinnamic acid hydrazide ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)butanoate (6S)-2-nitro-6-[((2E)-3-{4-[6-trifluoromethyl-3-pyridinyl]phenyl}-2-propenyl)oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine ethyl (2E)-3-(4-{[(3R)-1-(4-chlorobenzoyl)-3-pyrrolidinyl]amino}phenyl)acrylate 3-(4-bromophenyl)-2,2-dimethylcyclopentanone 3-[4-(Naphthalen-2-yloxy)-phenyl]-propionic acid ethyl ester (3R,4S)-4-{4-[(E)-2-(2-aminophenylcarbamoyl)-vinyl]-phenyl}-1-methyl-pyrrolidine-3-carboxylic acid (4-chlorophenyl)amide trans-2-Methoxycarbonyl-3-(4-brom-phenyl)-pyrrolidon-5 2-{3-[4-(Naphthalen-2-yloxy)-phenyl]-propionylamino}-benzoic acid methyl ester ethyl (Z)-3-(4-bromophenyl)-prop-2-enoate {2-[2-benzylcarbamoyl-1-(4-bromophenyl)-ethyl]-cyclohexylidenemethyl}-(4-methoxyphenyl)-carbamic acid tert-butyl ester (1S,2S)-[2-(4-bromophenyl)cyclopropyl]methanol combretastatin D-2 benzyl ether 1-bromo-4-[(E)-3-(2-methylallyloxy)prop-1-enyl]benzene 5-(4-bromophenyl)-2-(1-phenylethyl)-2,4,5,5a,6,7,8,9-octahydrobenzo[c]azepin-3-one (2S,3R)-3-(4-bromophenyl)-3-(2-ethoxyphenoxy)propane-1,2-diol [5-benzylcarbamoyl-4-(4-bromophenyl)-2-methyl-3-phenylpent-1-enyl]-(4-methoxyphenyl)-carbamic acid tert-butyl ester (2S,3R)-2-[(4-bromophenyl)-(2-ethoxyphenoxy)methyl]morpholin-5-one (2S,3R)-3-(4-bromophenyl)-3-(2-ethoxyphenoxy)-1-(toluenesulfonyloxy)propan-2-ol 3-[4-(Naphthalen-2-yloxy)-phenyl]-propionyl chloride 5-phenyl-2-(1-phenylethyl)-decahydrobenzo[c]azepine 1-benzyl-6-methyl-4,5-diphenylazepan-2-one 3-(4-bromophenyl)-3-(2-{[tert-butoxycarbonyl-(4-methoxyphenyl)amino]-methylene}cyclohexyl)propionic acid ethyl ester (2S,3R)-2-[(4-iodophenyl)-(2-ethoxyphenoxy)methyl]-N-tert-butoxycarbonylmorpholine 3-(4-i-propylphenyl)propionic acid 3-(4-bromophenyl)propyl ester 2,2-Dimethyl-propionic acid (2R,3R)-3-{4-[2-benzyloxy-5-(2-carboxy-ethyl)-phenoxy]-phenyl}-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-propyl ester (2S,3R)-1-amino-3-(4-bromophenyl)-3-(2-ethoxyphenoxy)propan-2-ol (2S,3R)-2-[(4-bromophenyl)-(2-ethoxyphenoxy)methyl]morpholine (E)-5-(4-bromophenyl)hex-2-enoic acid ethyl ester {2-[1-(4-bromophenyl)-2-methylcarbamoylethyl]-cyclohexylidenemethyl}-(4-methoxyphenyl)-carbamic acid tert-butyl ester 3-(1H-indol-3-yl)propionic acid 3-(4-bromophenyl)propyl ester (2R,3S)-2,3-dibromo-3-(4-bromophenyl)propan-1-ol 2-benzyl-5-(4-bromophenyl)-2,4,5,5a,6,7,8,9-octahydrobenzo[c]azepin-3-one (2S,3R)-2-[(4-bromophenyl)-(2-ethoxyphenoxy)methyl]-N-tert-butoxycarbonylmorpholine 5-{4-[(1E)-3-bromo-1-propenyl]phenyl}-2-(trifluoromethyl)pyridine (13R,14R)-4-hydroxy-13,14-dihydroxy-2,11-dioxatricyclo[13.2.2.13,7]eicosa-1(18),3,5,7(20),1(19),16-hexaen-10-one (2S,3R)-1-chloroacetylamino-3-(4-bromophenyl)-3-(2-ethoxyphenoxy)propan-2-ol 3-(4-chlorophenyl)propionic acid 3-(4-bromophenyl)propyl ester 3-{3-[4-((E)-3-Hydroxy-propenyl)-phenoxy]-4-methoxy-phenyl}-propionic acid ethyl ester (2-(4-bromophenyl)cyclopropyl)methanol {2-[1-(4-bromophenyl)-2-(1-phenylethylcarbamoyl)-ethyl]-cyclohexylidenemethyl}-(4-methoxyphenyl)-carbamic acid tert-butyl ester combretastatin D-1 benzyl ether (12S,13R)-46-(benzyloxy)-3,8-dioxa-1(2,3)-oxirana-2(1,4),4(1,3)-dibenzenacyclononaphan-7-one 3-[4-(Naphthalen-2-yloxy)-phenyl]-propionic acid 1-benzyl-3-methyl-4,5-diphenylazepane 5-phenyl-2-(1-phenylethyl)-decahydrobenzo[c]azepin-3-one 1-benzyl-4-(4-bromophenyl)-6-methyl-5-phenyl-1,3,4,5-tetrahydroazepin-2-one